REPLY
30.9.2021 09:32:08 CEST | Business Wire | Press release
Reply , with its award-winning companies Cluster Reply, Solidsoft Reply, Valorem Reply, WM Reply and Business Elements, announced today that it has received Microsoft Advanced Specialization status across six categories in five months.
Microsoft Advanced Specialization status denotes deep knowledge in a specific area, and between February and June, Reply – already a Microsoft Gold Partner in Europe, North and Latin America, and a Microsoft Azure Expert Managed Services Provider (MSP) – received specialist status in:
- Microsoft Windows Virtual Desktop
- Windows Server and SQL Server Migration to Microsoft Azure
- Kubernetes on Microsoft Azure
- Modernization of Web Applications to Microsoft Azure
- Calling for Microsoft Teams
- Analytics on Microsoft Azure
In addition to the 16 Microsoft Gold competencies held by Reply that show broad technical capability in a Microsoft product, Advanced Specialization status is reserved for partners meeting stringent criteria with regards customer success and staff skilling.
The first half performance builds upon a successful 2020, when Reply was awarded the Microsoft “Adoption and Change Management Advanced Specialization” in recognition of its deep knowledge, extensive experience, and proven success driving organizational change through Microsoft 365.
Filippo Rizzante, CTO Reply , said: "We are pleased of these recognitions which attest the technical skills and the expertise of our teams to successfully implement Microsoft services and solutions. Through our partnership with Microsoft we have achieved great results and we are proud of the success of our teams, confirmed by the seven Advanced Specializations achieved so far. We will continue to keep the pace over the coming months to get new specializations in order to help customers to become agile, resilient and innovative market leaders with the support of modern cloud technologies."
The Advanced Specializations at a glance:
- The “Microsoft Windows Virtual Desktop” Advanced Specialization validates Reply’s deep expertise in deploying and scaling virtualized desktops and applications on Azure using Windows Virtual Desktop;
- The “Windows Server and SQL Server Migration to Microsoft Azure” Advanced Specialization demonstrates Reply’s expertise in migrating and optimizing Windows Server and SQL Server-based workloads to Microsoft Azure;
- The “Kubernetes on Microsoft Azure” Advanced Specialization allows Reply to further differentiate itself by demonstrating the proven success in deploying and managing production workloads in the cloud using containers and managing hosted Kubernetes environments in Microsoft Azure;
- The “Modernization of Web Applications to Microsoft Azure” Advanced Specialization confirms Reply’s expertise and proven success in migrating and deploying production web application workloads, applying DevOps practices, and managing application services in Microsoft Azure;
- The “Calling for Microsoft Teams” Advanced Specialization demonstrates deep knowledge, extensive experience, and proven success in deploying and managing Microsoft 365 Phone System;
- The “Analytics on Microsoft Azure” Advanced Specialization validates Reply’s deep expertise in planning and deploying Azure cloud analytics services, enabling customers to use the full breadth of their data assets to help build transformative and secure analytical solutions at enterprise scale.
Reply
Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of AI, big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210930005034/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release
Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures
IHS Towers Publishes 2025 Sustainability Report26.5.2026 12:34:00 CEST | Press release
IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom